Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Xenon Pharmaceuticals Inc. - Common Shares (NQ:XENE)

63.10 -1.84 (-2.83%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	703,523
Open	65.32
Bid (Size)	60.15 (1,000)
Ask (Size)	68.00 (100)
Prev. Close	64.94
Today's Range	62.85 - 65.64
52wk Range	30.00 - 72.66
Shares Outstanding	63,562,303
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 02, 2026

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 29, 2026

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Performance

YTD	+41.8%	+41.8%
1 Month	+4.9%	+4.9%
3 Month	+15.7%	+15.7%
6 Month	+48.9%	+48.9%
1 Year	+103.7%	+103.7%

More News

What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing ↗

May 18, 2026

Via The Motley Fool

Xenon Pharmaceuticals (NASDAQ:XENE) Reports Mixed Q1 Results as Azetukalner Nears FDA Submission ↗

May 07, 2026

Via Chartmill

XENON PHARMACEUTICALS INC (NASDAQ:XENE) Breakout Setup Combines 9/10 Technical Strength with 9/10 Consolidation Quality ↗

May 02, 2026

Via Chartmill

Xenon Pharmaceuticals Q1 Earnings Call Highlights ↗

May 09, 2026

Via MarketBeat

Xenon (XENE) Q1 2026 Earnings Transcript ↗

May 07, 2026

Via The Motley Fool

Xenon Reports Q1 2026 Financial Results and Provides Business Update

May 07, 2026

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 01, 2026

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon to Report Q1 2026 Financial Results on May 7, 2026

April 30, 2026

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting

April 19, 2026

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon to Present at Upcoming Investor Conferences

April 15, 2026

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting

April 07, 2026

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know ↗

March 27, 2026

Via The Motley Fool

This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough ↗

March 13, 2026

Via The Motley Fool

Battery Storage Stock Up 50% in a Year Draws New $110M Investment. Here's What You Should Know ↗

March 13, 2026

Via The Motley Fool

Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings ↗

March 13, 2026

Via The Motley Fool

Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

March 12, 2026

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)

March 12, 2026

Via Finterra

Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering

March 10, 2026

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

The Potassium Channel Breakthrough: A Deep-Dive on Xenon Pharmaceuticals (XENE)

March 10, 2026

Via Finterra

XENE Stock Rallies 50% On Epilepsy Trial Data, But One Analyst Thinks Rival Biohaven Still Has ‘Room To Differentiate’ ↗

March 09, 2026

Via Stocktwits

Xenon Pharmaceuticals Announces Proposed Public Offering

March 09, 2026

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Top stock movements in today's session. ↗

March 09, 2026

Via Chartmill

Monday's session: top gainers and losers ↗

March 09, 2026

Via Chartmill

Frequently Asked Questions

Is Xenon Pharmaceuticals Inc. - Common Shares publicly traded?

Yes, Xenon Pharmaceuticals Inc. - Common Shares is publicly traded.

What exchange does Xenon Pharmaceuticals Inc. - Common Shares trade on?

Xenon Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares?

The ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares is XENE on the Nasdaq Stock Market

What is the current price of Xenon Pharmaceuticals Inc. - Common Shares?

The current price of Xenon Pharmaceuticals Inc. - Common Shares is 63.10

When was Xenon Pharmaceuticals Inc. - Common Shares last traded?

The last trade of Xenon Pharmaceuticals Inc. - Common Shares was at 07/29/26 04:00 PM ET

What is the market capitalization of Xenon Pharmaceuticals Inc. - Common Shares?

The market capitalization of Xenon Pharmaceuticals Inc. - Common Shares is 4.01B

How many shares of Xenon Pharmaceuticals Inc. - Common Shares are outstanding?

Xenon Pharmaceuticals Inc. - Common Shares has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.